Hosted by CellCAN in partnership with the Centre for Commercialization of Cancer Immunotherapy (C3i) and the Centre for Commercialization of Regenerative Medicine (CCRM), this Strategic Forum represents a great opportunity to identify concrete actions to help stakeholders become better equipped to develop cell, tissue and gene therapies.
